Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Effect of Dipyridamole in Carotid Revascularization
NCT02630862Completed
- Sponsor
- Sapienza University of Rome
- Start
- Sep 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dipyridamole in stroke and Transient Ischemic Attack (TIA) (2 arms), sponsored by Sapienza University of Rome. Primary endpoints: Plasma Oxysterol Level at 6 months and Plasma Vitamin E (alpha- and gamma-tocopherol) Level at 6 months. Started Sep 2010; status: completed.
02
Drugs
dipyridamole
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02630862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630862.